The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Topical ABT-263 effectively reduced several senescence markers in aged skin, preparing it for improved wound healing.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...

Breakthrough study in Nature Materials reveals DNA nanorafts reshape synthetic cells for controlled membrane dynamics and ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for ...